-
Product Name
Cynomolgus B7-H3/CD276 (Fc Tag) recombinant protein
- Documents
-
Description
B7-H3 is a member of the B7 family of immune regulatory ligands that is thought to attenuate peripheral immune responses through co-inhibition. It plays an important role in adaptive immune responses, and was shown to either promote or inhibit T-cell responses in various experimental systems. B7-H3 may play an important role in muscle-immune interactions, providing further evidence of the active role of muscle cells in local immunoregulatory processes. B7-H3 is a novel protein structurally related to the B7 family of ligands by the presence of a single set of immunoglobulin-V-like and immunoglobulin-C-like (VC) domains. Previous studies have correlated its overexpression with poor prognosis and decreased tumor-infiltrating lymphocytes in various carcinomas including uterine endometrioid carcinomas, and mounting evidence supports an immuno-inhibitory role in ovarian cancer prognosis. Recently, B7-H3 expression has been reported in several human cancers indicating an additional function of B7-H3 as a regulator of antitumor immunity.
-
Protein short names
6030411F23RIK; B7RP-2; 4IG-B7-H3; AU016588; B7-H3; B7H3; PSEC0249; CD276
-
Uniprot ID
F7G5V3
-
Source/Expression Host
Human Cells
-
Expression Plasmid/cDNA
A DNA sequence encoding the cynomolgus CD276 (XP_005560056.1) (Met1-Glu465) was expressed with the Fc region of human IgG1 at the C-terminus.
-
Protein Species
Cynomolgus
-
Molecular weight
The recombinant cynomolgus CD276 consists 675 amino acids and predicts a molecular mass of 73.8 kDa.
-
Purity
> 90 % as determined by SDS-PAGE.
-
Validations
Cynomolgus B7-H3 / CD276 Protein (Fc Tag)
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"